Celtarys Research

celtarys.com ↗ ·Santiago de Compostela ·Seed

Celtarys Research is a biotech company spun out of the University of Santiago de Compostela in 2021 that develops and commercializes fluorescent chemical tools (ligands, biotinylated probes) used to replace radioactive methods in high-throughput screening and drug discovery, focused on GPCRs, E3 ligases and intracellular receptors. It positions itself as the only company exclusively dedicated to fluorescent probes replacing radioactivity, and works with 40+ clients in 14 countries. It is headquartered in Santiago de Compostela, Galicia.

Founded
2021
Founders
8
Total funds raised
€650K
Rounds
1
Investors
2
Last round
Sep 2021
SectorsBiotech, Drug Discovery Tools, Chemical Biology Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Eddy Sotelo
Co-founder & Chairman of the Board
Javier Sardina
Co-founder
Jhonny Azuaje
Co-founder
Jose Brea (Pepo Brea)
Co-founder
Jose Manuel Santamaría Pérez
Co-founder / Board Member
Mabel Loza
Co-founder
Maria Majellaro
Co-founder & Chief Scientific Officer
Sonia Martínez Arca
Co-founder (former CEO)

Global models 5

Twist Bioscience
A life-science tools company that commercializes proprietary synthesis technology as reagents/kits for biopharma R&D, similar to Celtarys selling proprietary chemical-tool kits into drug discovery workflows.
$291MComparable
10x Genomics
United States · www.10xgenomics.com ↗
An academic-spinout life-science tools company selling proprietary reagent/instrument kits that enable biological research and drug discovery, the same reagents-for-research-labs business model as Celtarys.
$277MComparable
Berkeley Lights (PhenomeX)
United States · www.bruker.com ↗
A life-science tools company providing cell-based screening technology to pharma/biotech customers for drug discovery, comparable to Celtarys' assay/screening tools for HTS.
$152MComparable
Mission Bio
United States · missionbio.com ↗
An academic-adjacent life-science tools company selling a proprietary single-cell analysis platform/reagents into pharma R&D, the same tools-for-drug-discovery model as Celtarys.
$120MComparable
Nautilus Biotechnology
United States · www.nautilus.bio ↗
A life-science tools startup commercializing a novel proprietary biomolecular detection platform for research/drug discovery customers, comparable in model to Celtarys' proprietary probe technology.
$109MComparable

In the same niche 26 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 2

Open as list →

Funding rounds 1

DateRoundAmountLead

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list